Skip to main content

Table 1 Patient demographics

From: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer

Characteristics N = 10
Mean (range) age, years 57.9 ± 9.6 (43–74)
Performance status*, n (%)  
   80% 4 (40)
   90% 3 (30)
   100% 3 (30)
Sex, n (%)  
   Male 7 (70)
   Female 3 (30)
Race, n (%)  
   Caucasian 9 (90)
   Blacks/Asians 1 (10)
Prior therapy, n (%)  
   Chemotherapy  
1 prior regimen 4 (40)
≥2 prior regimens 6 (60)
   Radiotherapy 5 (50)
   Immunotherapy 0 (0)
   Other 1 (10)
HLA-A2†, n (%)  
   Positive 3 (30)
   Negative 7 (70)
  1. Abbreviation: †HLA-A2, human leukocyte antigen-A2; * Karnofsky Performance Status (KPS)